Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: From experimental models to human trials
Authors:
- Jacob GeorgeJGJacob George
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 115 (1) , 25-36
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarctionCytokine, 2006
- Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor CellsTissue Engineering, 2006
- Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E‐cadherinFEBS Letters, 2005
- Treatment with granulocyte colony–stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarctionAmerican Heart Journal, 2005
- Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humansInternational Journal of Cardiology, 2005
- Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart diseaseInternational Journal of Cardiology, 2005
- Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctionsInternational Journal of Cardiology, 2004
- Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial InjuryCirculation, 2003
- Aging, Progenitor Cell Exhaustion, and AtherosclerosisCirculation, 2003
- Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantationThe Lancet, 2003